Literature DB >> 16389651

Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey.

Katherine J Stevens1, Christopher J McCabe, John E Brazier.   

Abstract

We examine the relationship between Visual Analogue Scale (VAS) and Standard Gamble (SG) assumed in the development of the multiplicative multi-attribute utility functions (M-MAUFs) for the Health Utilities Index (HUI) Mark 2 and Mark 3, using data from a UK valuation study of the HUI2. A range of functional forms are considered, and are compared on the basis of their explanatory power and predictive ability.A restricted cubic function fits the data better than a power curve with a mean absolute error (MAE) of 0.025 and root mean square error (RMSE) of 0.029 compared to a MAE of 0.135 and RMSE of 0.135 for the power curve. The use of a cubic mapping function instead of a power function leads to different predicted health state values. We question the reliance on the assumption of a power curve relationship between VAS and SG data, in the Health Utilities Index valuation framework. Our results demonstrate that further work is required to examine the appropriateness of the published M-MAUFs for the Health Utilities Indices.

Entities:  

Mesh:

Year:  2006        PMID: 16389651     DOI: 10.1002/hec.1076

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  8 in total

1.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 2.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 3.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

4.  Measuring health utility in varying pregnancy contexts among a diverse cohort of pregnant women.

Authors:  Lisbet S Lundsberg; Xiao Xu; Eleanor B Schwarz; Aileen M Gariepy
Journal:  Contraception       Date:  2017-08-17       Impact factor: 3.375

5.  Mastopexy for breast ptosis: Utility outcomes of population preferences.

Authors:  Ahmed Ms Ibrahim; Hani H Sinno; Ali Izadpanah; Joshua Vorstenbosch; Tassos Dionisopoulos; Mark K Markarian; Bernard T Lee; Samuel J Lin
Journal:  Plast Surg (Oakv)       Date:  2015       Impact factor: 0.947

6.  Measuring the effects of unintended pregnancy on women's quality of life.

Authors:  Eleanor Bimla Schwarz; Rachel Smith; Jody Steinauer; Matthew F Reeves; Aaron B Caughey
Journal:  Contraception       Date:  2008-07-22       Impact factor: 3.375

7.  Nipple-areolar Complex Reconstruction following Postmastectomy Breast Reconstruction: A Comparative Utility Assessment Study.

Authors:  Ahmed M S Ibrahim; Hani H Sinno; Ali Izadpanah; Joshua Vorstenbosch; Tassos Dionisopoulos; Marc A M Mureau; Adam M Tobias; Bernard T Lee; Samuel J Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-05-07

8.  The utility of outcome studies in plastic surgery.

Authors:  Hani Sinno; Tassos Dionisopoulos; Sumner A Slavin; Ahmed M S Ibrahim; Kevin C Chung; Samuel J Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.